Associated investigators

Associated investigators Daniela Elena Costea, Camilla Krakstad, Elisabeth Wik, Carina Strell, Agnete Engelsen, Inge Jonassen, John Cairns and Ole-Frithjof Norheim.

Daniela Elena Costea

Professor Daniela Elena Costea and her team in the Experimental Pathology Research Group are focusing on on tumor-stroma interactions for identification of tumor microenvironment-related prognostic biomarkers.

Camilla Krakstad

Professor Camilla Krakstad has her background from research on signal transduction, and during her PhD, she studied cAMP signaling in apoptotic cell death in both normal and cancer cells. She is now leader of the the Bergen Gynecologic Cancer Research Group.

Elisabeth Wik

Dr. Elisabeth Wik has been a cancer researcher since 2007. She holds the position as Head of Department of Pathology (Haukeland University Hospital), Associate Professor at Centre for Cancer Biomarkers CCBIO and Department of Clinical Medicine, University of Bergen, and has since 2018 been head of...

Carina Strell

The research in Strell’s group focuses on the biology of breast ductal carcinoma in situ (DCIS), with the overall ambition to comprehensively elucidate the underlying regulatory signaling mechanisms of early breast cancer evolution towards clinical disease progression and therapy response.

Agnete Engelsen

The Engelsen group is dedicated to exploring how phenotypic plasticity interferes with therapeutic efficacy and immune cell-mediated killing.

Bioinformatics and Big Data

Professor Inge Jonassen and part of his team from the CBU (Computational Bioinformatics Unit, Department of Informatics, UiB) are working on the development and application of bioinformatics methods for analysing data descending from high-throughput measurement technologies applied to cancer samples.

Health Economics

Health economics at CCBIO is concerned with two major research problems: what is the cost-effectiveness of biomarkers, and how does the interplay between the diagnostic market and the pharmaceutical market affect incentives to invest in R&D for cancer biomarkers, termed the industrial...

Global Health Priorities - Ole-Frithjof Norheim

Global Health Priorities is an interdisciplinary research group situated at the Department of Global Health and Primary Care at the University of Bergen. The group consists of a team of cross-disciplinary researchers and professionals dedicated to study the ethics and economics of priority setting...

19.05.2023